Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Chen, Wei Prof. Dr. (1) Daniel, Peter Prof. Dr. (1) Falcke, Martin Prof. Dr. (9) Hinz, Michael Dr. (2) Lusatis, Simone (1) Scheidereit, Claus Prof. Dr. (3) Selbach, Matthias Prof. Dr. (1) Wollert-Wulf, Brigitte (2) (-) Janz, Martin Dr. (11) (-) Mathas, Stephan Dr. (15) (-) Wolf, Jana Prof. Dr. (4) (-) Biologie maligner Lymphome (18) Experimentelle Ultrahochfeld-MR (1) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Klinik für Psychiatrie / Modul Psychiatrie des Alterns (1) Magnetic Resonance (1) (-) Mathematische Modellierung zellulärer Prozesse (4) (-) Mathematische Zellphysiologie (1) Proteom Dynamik (2) Zelluläre Neurowissenschaften (38) 1997 (2) 1999 (2) 2000 (4) 2001 (2) (-) 2002 (6) 2003 (4) (-) 2004 (5) 2005 (4) (-) 2006 (5) 2007 (5) 2008 (6) 2009 (4) 2010 (6) (-) 2011 (6) 2012 (3) 2013 (6) 2014 (3) 2015 (9) 2016 (5) 2017 (7) 2018 (3) 2019 (7) 2020 (12) 2021 (9) 2022 (9) 2023 (14) 2024 (2) 22 Ergebnisse: Active Filter: Janz, Martin Dr.Mathas, Stephan Dr.Wolf, Jana Prof. Dr.Biologie maligner LymphomeMathematische Modellierung zellulärer ProzesseMathematische Zellphysiologie2002200420062011 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 15. April 2002 / Blood Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease F. Jundt K. Kley I. Anagnostopoulos K. Schulze-Proebsting A. Greiner S. Mathas C. Scheidereit T. Wirth H. Stein B. Doerken 01. Mai 2002 / Blood Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma F. Jundt I. Anagnostopoulos R. Foerster S. Mathas H. Stein B. Doerken 01. Januar 2002 / Int J Cancer Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1 M. Janz N. Harbeck P. Dettmar U. Berger A. Schmidt K. Juerchott M. Schmitt H.D. Royer 01. November 2002 / Blood In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp 130/STAT3 pathway M. Chatterjee D. Hoenemann S. Lentzsch K. Bommert C. Sers P. Herrmann S. Mathas B. Doerken R.C. Bargou 01. August 2002 / EMBO J Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B S. Mathas M. Hinz L. Anagnostopoulos D. Krappmann A. Lietz F. Jundt K. Bommert F. Mechta-Grigoriou H. Stein B. Dörken C. Scheidereit 14. April 2011 / Oncogene High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas K. Koechert K. Ullrich S. Kreher J.C. Aster M. Kitagawa K. Joehrens I. Anagnostopoulos F. Jundt B. Lamprecht U. Zimber-Strobl H. Stein M. Janz B. Doerken S. Mathas 01. November 2004 / Biophys J Modeling feedback loops of the Mammalian circadian oscillator S. Becker-Weimann J. Wolf H. Herzel A. Kramer 16. Februar 2011 / Biophys J Metabolic synchronization by traveling waves in yeast cell layers J. Schuetze T. Mair M.J. Hauser M. Falcke J. Wolf 02. September 2002 / J Exp Med Nuclear factor κB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity M. Hinz P. Lemke I. Anagnostopoulos C. Hacker D. Krappmann S. Mathas B. Doerken M. Zenke H. Stein C. Scheidereit 15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas Seitennummerierung Aktuelle Seite 1 Seite 2 Seite 3 Nächste Seite Next › Letzte Seite Last »
15. April 2002 / Blood Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease F. Jundt K. Kley I. Anagnostopoulos K. Schulze-Proebsting A. Greiner S. Mathas C. Scheidereit T. Wirth H. Stein B. Doerken
01. Mai 2002 / Blood Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma F. Jundt I. Anagnostopoulos R. Foerster S. Mathas H. Stein B. Doerken
01. Januar 2002 / Int J Cancer Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1 M. Janz N. Harbeck P. Dettmar U. Berger A. Schmidt K. Juerchott M. Schmitt H.D. Royer
01. November 2002 / Blood In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp 130/STAT3 pathway M. Chatterjee D. Hoenemann S. Lentzsch K. Bommert C. Sers P. Herrmann S. Mathas B. Doerken R.C. Bargou
01. August 2002 / EMBO J Aberrantly expressed c-Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF-kappa B S. Mathas M. Hinz L. Anagnostopoulos D. Krappmann A. Lietz F. Jundt K. Bommert F. Mechta-Grigoriou H. Stein B. Dörken C. Scheidereit
14. April 2011 / Oncogene High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas K. Koechert K. Ullrich S. Kreher J.C. Aster M. Kitagawa K. Joehrens I. Anagnostopoulos F. Jundt B. Lamprecht U. Zimber-Strobl H. Stein M. Janz B. Doerken S. Mathas
01. November 2004 / Biophys J Modeling feedback loops of the Mammalian circadian oscillator S. Becker-Weimann J. Wolf H. Herzel A. Kramer
16. Februar 2011 / Biophys J Metabolic synchronization by traveling waves in yeast cell layers J. Schuetze T. Mair M.J. Hauser M. Falcke J. Wolf
02. September 2002 / J Exp Med Nuclear factor κB-dependent gene expression profiling of Hodgkins disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity M. Hinz P. Lemke I. Anagnostopoulos C. Hacker D. Krappmann S. Mathas B. Doerken M. Zenke H. Stein C. Scheidereit
15. Mai 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas